The Maine Prescription Drug Affordability Board (MPDAB) was established in 2019 pursuant to MRS Title 5 Chapter 167-1. The Maine Office of Affordable Health Care provides staffing support to the Board.
MPDAB Mission: To determine annual spending targets for prescription drugs purchased by Maine public payers and make recommendations to achieve the targets.
MPDAB Vision: Board recommendations will target strategies to achieve prescription drug affordability while maintaining safety and ensuring clinically appropriate use. The spending targets will be based upon a 10- year rolling average of the medical care services component plus a reasonable percentage for inflation and minus a spending target determined by the board for pharmacy savings. In addition, spending targets will be determined on specific prescription drugs that may cause affordability challenges to enrollees.
View the 2024 MPDAB Annual Report here.
Board Members:
- Chair: Kelsie Snow, PharmD
- Peter Hayes
- Sharon Treat
- Susan Wehry, MD
- Julia Redding, DO
- Noah Nesin, MD (alternate)
- Jennifer Reck (alternate)
- Rhonda Selvin, FNP (alternate)
Upcoming Meetings
View upcoming meetings
Meeting Records
View meeting records